Orgovyx 120 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV5C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,141
Award facts
- Contract value 100% obligated
- $13,141.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 28, 2026, provides ORGOVYX 120 mg tablets (30-count units) to the Defense Logistics Agency (DLA) through Amerisourcebergen Drug Corp, a pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is valued at $13,141.17 with a firm fixed price structure and an ultimate completion date of February 19, 2026. This award was made on a competitive, non-set-aside basis and represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 vehicle authorized through December 2026 that supplies pharmaceutical products and medical commodities globally to military healthcare programs.
ORGOVYX is a hormone therapy medication used primarily in the treatment of advanced prostate cancer, reflecting DLA's ongoing procurement of specialized pharmaceutical products to support military medical treatment facilities and veterans' healthcare systems. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), which serves as the parent organization and holds the overarching IDC with DLA. The DLA Medical Supply Chain leverages such delivery orders to maintain adequate inventory of critical pharmaceutical products across its global distribution network supporting the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FQV5C?
SPE2DR26FQV5C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FQV5C worth?
The government has obligated $13,141 on SPE2DR26FQV5C.
Is contract SPE2DR26FQV5C an order under another contract?
Yes. SPE2DR26FQV5C is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV5C competed?
The extent of competition for SPE2DR26FQV5C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award